EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow

Ratko Lasica iD, Milika Asanin, Jovanka Vukmirovic, Lidija Maslac iD, Lidija Savic iD, Marija Zdravkovic iD, Dejan Simeunovic, Marija Polovina, Aleksandra Milosevic, Dragan Matic iD, Stefan Juricic, Milica Jankovic und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910559 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ratko Lasica und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Emergency Center, University Clinical Center of Serbia, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Cardiomyopathies, Peripartum Period, Pregnancy Complications, Cardiovascular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripartum cardiomyopathy is a disease that occurs during or after pregnancy and leads to a significant decline in cardiac function in previously healthy women. Peripartum cardiomyopathy has a varying prevalence among women depending on the part of the world where they live, but it is associated with a significant mortality and morbidity in this population. Therefore, timely diagnosis, treatment, and monitoring of this disease from its onset are of utmost importance. Although many risk factors are associated with the occurrence of peripartum cardiomyopathy, such as conditions of life, age of the woman, nutrient deficiencies, or multiple pregnancies, the exact cause of its onset remains unknown. Advances in research on the genetic associations with cardiomyopathies have provided a wealth of data indicating a possible association with peripartum cardiomyopathy, but due to numerous mutations and data inconsistencies, the exact connection remains unclear. Significant insights into the pathophysiological mechanisms underlying peripartum cardiomyopathy have been provided by the theory of an abnormal 16-kDa prolactin, which may be generated in an oxidative stress environment and lead to vascular and consequently myocardial damage. Recent studies supporting this disease mechanism also include research on the efficacy of bromocriptine (a prolactin synthesis inhibitor) in restoring cardiac function in affected patients. Despite significant progress in the research of this disease, there are still insufficient data on the safety of use of certain drugs treating heart failure during pregnancy and breastfeeding. Considering the metabolic changes that occur in different stages of pregnancy and the postpartum period, determining the correct dosing regimen of medications is of utmost importance not only for better treatment and survival of mothers but also for reducing the risk of toxic effects on the fetus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesPeripartum PeriodPregnancy Complications, CardiovascularHumansFemalePregnancyProlactinRisk FactorsBromocriptineOxidative Stress

Stichwörter der Autor:innen

heart failureperipartum cardiomyopathypregnancyprognosistreatment

Substanzen

ProlactinBromocriptine

Autor:innen und Institutionen

  • Department of Cardiology, Emergency Center, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Department of Cardiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  • Faculty of Organizational Sciences, University of Belgrade, 11000 Belgrade, Serbia.
  • Clinical Center Bezanijska Kosa, 11000 Belgrade, Serbia.

ORCID-Profile: Ratko Lasica, Lidija Maslac, Lidija Savic, Marija Zdravkovic, Dragan Matic, Lazar Djukanovic

Zitieren

APA

Lasica, R., Asanin, M., Vukmirovic, J., Maslac, L., Savic, L., Zdravkovic, M., Simeunovic, D., Polovina, M., Milosevic, A., Matic, D., Juricic, S., Jankovic, M., Marinkovic, M., & Djukanovic, L. (2024). What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910559

Vancouver

Lasica R, Asanin M, Vukmirovic J, Maslac L, Savic L, Zdravkovic M, et al. What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910559

BibTeX
@article{Lasica2024,
  author = {Lasica, Ratko and Asanin, Milika and Vukmirovic, Jovanka and Maslac, Lidija and Savic, Lidija and Zdravkovic, Marija and Simeunovic, Dejan and Polovina, Marija and Milosevic, Aleksandra and Matic, Dragan and Juricic, Stefan and Jankovic, Milica and Marinkovic, Milan and Djukanovic, Lazar},
  title = {What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910559}
}
Kostenlos starten →